Michael J Duryee

Title: Michael J Duryee: Innovator in Cardiac Health

Introduction

Michael J Duryee is a notable inventor based in Omaha, NE (US). He has made significant contributions to the field of cardiac health through his innovative patents. With a total of 2 patents, Duryee's work focuses on methods for detecting coronary artery disease.

Latest Patents

Duryee's latest patents include a "Kit for detecting coronary artery disease comprising an MAA protein adduct and reagents that bind to antibodies." This invention provides methods for identifying mammals at an elevated risk for adverse cardiac events, such as myocardial infarction (MI). The methods involve determining the presence and/or level of antibodies that bind to malondialdehyde acetaldehyde adduct (MAA adduct) in biological samples. An elevated level of these antibodies indicates the presence of atherosclerotic lesions and an increased risk for MI.

Another significant patent is "Circulating antibodies against MAA adducts as a biomarker for coronary artery disease." Similar to his previous work, this invention outlines methods for identifying mammals at risk for adverse cardiac events by measuring the levels of anti-MAA adduct antibodies in biological samples.

Career Highlights

Michael J Duryee is affiliated with the University of Nebraska, where he continues to advance research in cardiac health. His innovative approaches have the potential to improve diagnostic methods and patient outcomes in cardiology.

Collaborations

Duryee has collaborated with notable colleagues, including Geoffrey M Thiele and Daniel R Anderson. Their combined expertise contributes to the advancement of research in the field of cardiac health.

Conclusion

Michael J Duryee's contributions to cardiac health through his innovative patents demonstrate his commitment to improving medical diagnostics. His work has the potential to significantly impact the detection and prognosis of coronary artery disease.